Tech Center 1600 • Art Units: 1648 1654 1671 1675
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18029467 | METHODS FOR DETECTING ANTIBODIES | Final Rejection | The Regents of the University of California |
| 18252800 | MODIFIED SECRETED HEPATITIS C VIRUS (HCV) E1E2 GLYCOPROTEINS AND METHODS OF USE THEREOF | Non-Final OA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 18050806 | THERAPEUTIC AND PREVENTATIVE CANCER VACCINES | Non-Final OA | Arizona Board of Regents on Behalf of Arizona State University |
| 17747358 | MULTIGENIC MVA-SARS-COV-2 VACCINE | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18684496 | FMDV VIRUS-LIKE PARTICLE WITH DOUBLE STABILIZING MUTATION | Non-Final OA | THE PIRBRIGHT INSTITUTE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy